Taltz and Eosinophil count increased - a phase IV clinical study of FDA data

Summary:

Eosinophil count increased is reported as a side effect among people who take Taltz (ixekizumab), especially for people who are female, 50-59 old, also take Augmentin, and have Arthritis.

The phase IV clinical study analyzes which people have Eosinophil count increased when taking Taltz. It is created by eHealthMe based on reports of 29,745 people who have side effects when taking Taltz from the FDA, and is updated regularly.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,778 Taltz users. Check the latest studies of Taltz.

What is Eosinophil count increased?

Eosinophil count increased is found to be associated with 771 drugs and 1,130 conditions by eHealthMe. Check the latest studies of Eosinophil count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

29,745 people reported to have side effects when taking Taltz.
Among them, 14 people (0.05%) have Eosinophil count increased.

Could Taltz cause Eosinophil count increased?

Among these 14 people:

What is the gender of people who have Eosinophil count increased when taking Taltz? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Eosinophil count increased when taking Taltz? *

What are other drugs people take besides Taltz? *

Methotrexate: 8 people, 57.14%
Humira: 8 people, 57.14%
Augmentin: 8 people, 57.14%
Prednisolone: 7 people, 50.00%
Plaquenil: 5 people, 35.71%
Methotrexate Sodium: 3 people, 21.43%
Hydroxychloroquine Sulfate: 3 people, 21.43%
Cymbalta: 2 people, 14.29%
Methylprednisolone Sodium Succinate: 1 person, 7.14%

What are other side effects people have besides Eosinophil count increased? *

Rash Pustular (redness with pustules): 9 people, 64.29%
Toxic Skin Eruption (skin breakdown due to toxic substance): 8 people, 57.14%
Paleness (unusual lightness of skin colour): 8 people, 57.14%
Back Pain: 8 people, 57.14%
Cell Death: 8 people, 57.14%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 8 people, 57.14%
Dermatitis Exfoliative Generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface): 8 people, 57.14%
Dermatitis Psoriasiform (large white or silver flakes on the skin): 8 people, 57.14%
Dyspnea (difficult or laboured breathing): 8 people, 57.14%
Epidermal Necrosis (skin condition that is usually caused by a reaction to drugs): 8 people, 57.14%

What are the existing conditions these people have? *

Thyroid Diseases: 8 people, 57.14%
Joint Pain: 8 people, 57.14%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 57.14%
High Blood Pressure: 5 people, 35.71%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 21.43%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 14.29%
Lupus-Like Syndrome (a disease symptom matches with lupus an immune disease): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Taltz and have Eosinophil count increased?

- Check whether Eosinophil count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taltz:

Taltz (29,778 reports)

Browse all side effects of Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eosinophil count increased:

Eosinophil count increased (771 drugs)

Browse all the conditions that are associated with Eosinophil count increased:

Eosinophil count increased (1,130 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ixekizumab (the active ingredients of Taltz) and Taltz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.